MannKind Corporation announced that CEO Michael Castagna will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 3, 2026. The event will be webcast live and available on MannKind's website, offering investors insights into the company's focus on innovative treatments for chronic diseases like diabetes and pulmonary conditions. This presentation highlights MannKind's ongoing efforts to advance patient-centric therapies and could provide updates on their drug-device combination products and business progress.
VINCI has finalized its acquisition of Fletcher Construction, a major New Zealand company with annual revenue of about €630 million and 2,300 employees. This move strengthens VINCI Construction's position in New Zealand's growing infrastructure marke...
VINCI has finalized its acquisition of Fletcher Construction, a New Zealand company with annual revenue of about 630 million euros and 2,300 employees. This move strengthens VINCI Construction's network in New Zealand, complementing previous acquisit...
Tryg A/S hosted its Analyst Day 2026 on May 28 at its headquarters, focusing on presentations from various business units. The event was aimed at sell-side analysts covering the company's shares. No new financial or strategic targets were revealed du...
Sunshine Biopharma shares fell 5.17% in after-hours trading following the announcement of a one-for-ten reverse stock split effective June 1, 2026. The reverse split aims to meet Nasdaq's minimum bid price requirement by consolidating every ten share...
Between May 21 and May 27, 2026, Bekaert bought back 51,190 shares at an average price of €41.48, totaling about €2.12 million, as part of its ongoing share buyback program aimed at canceling repurchased shares. Additionally, under its liquidity agre...
